Kewalramani Reshma sold VRTX
May 20, 2024 · Form 4 insider transaction
Kewalramani Reshma sold 15,202 shares of Vertex Pharmaceuticals Incorporated at $447.00 per share, a transaction worth $6.80M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
15,202
Price
$447.00
Total value
$6.80M
InsiderKewalramani Reshma
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 20, 2024
Filing dateMay 22, 2024
Shares owned after121,374
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1, which was entered into on 02/07/2024.